Akorn Shares Rally Following Increased Price Target
Shares of Akorn (NASDAQ: AKRX) were up nearly 10 percent Tuesday around $36.50 following the release of a Needham note in which the price target for the company was raised from $30 to $40.
The note cited a "game changing" effect if Akorn matches Taro Pharmaceutical Industries' recent price increases in topical generics.
Shares are currently up 5.25 percent at $34.99.
Latest Ratings for AKRX
|Mar 2017||Deutsche Bank||Downgrades||Buy||Hold|
|Dec 2016||Goldman Sachs||Initiates Coverage On||Sell|
|Nov 2016||Bank of America||Downgrades||Buy||Underperform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.